Citation Tools

Extended report
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

Download to a citation manager

Cite this article as:
Burmester GR, Mease P, Dijkmans BAC, et al
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases